John Paulson, Director at Valeant Pharmaceuticals International, Inc. (VRX), sold 14,133,258 shares at $15.40 ($217.7M) on 2018-03-06, disclosed to the SEC on 2018-03-08.
Open-market sale of $217.7M VRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.40 | 7,066,629 | $108.8M | 50.0% |
| 2 | $15.40 | 7,066,629 | $108.8M | 50.0% |
| Total | $15.40 avg | 14,133,258 | $217.7M | 100% |
| Filing → |
| BHC | BUY | 2025-06-17 | $42.3M | — | Filing → |
| BHC | BUY | 2025-06-12 | $29.4M | — | Filing → |
| BSIG | BUY | 2020-06-26 | $12.7M | — | Filing → |